Quantum BioPharma
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -129 | -112 | ||
EBITDA | -9,389 | -8,259 | -5,327 | |
EBIT | -9,530 | -8,389 | -5,439 | |
Net Income | -5,319 | -9,253 | -8,576 | -5,360 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,721 | -1,949 | -4,247 | -835 |
Cash | 445 | 1,497 | 3,518 | 5,995 |
Basic Shares | 3,815 | 3,021 | 1,136 | 1,027 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -490 | |||
EBITDA | -14,377 | -15,723 | -22,117 | -29,823 |
EBIT | -14,867 | -18,230 | -26,654 | -33,868 |
Net Income | -14,202 | -17,902 | -23,606 | -35,285 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -6,876 | -10,827 | -28,697 | -21,246 |
Cash | 5,995 | 2,757 | 16,980 | 35,259 |
Basic Shares | 1,136 | 609 | 595 | 537 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$3.06 |
2025-03-31 | -$2.33 |
2024-12-31 | -$2.70 |
2024-09-30 | -$4.16 |
